Benzinga reports Bone Health Technologies raises $2.5M to advance Osteoboost, the FDA-cleared wearable combating bone loss in postmenopausal women.

Laura Yecies shares how Osteoboost, an FDA-cleared wearable, helps postmenopausal women improve bone health through vibration therapy.

San Francisco Business Times highlights Laura Yecies' efforts to address gender disparities in medical research through innovations like Osteoboost.

MD+DI covers Osteoboost, a NASA-inspired vibration belt designed to prevent osteoporosis by aiding postmenopausal women in maintaining bone strength.

Margie Bissinger interviews CEO Laura Yecies on Osteoboost, the FDA-cleared wearable using vibration therapy to combat bone loss in postmenopausal women.

BioWorld reports on Osteoboost's FDA Breakthrough Device designation, highlighting its innovative approach to preventing osteoporosis through vibration therapy.

Healio reports on Osteoboost, an FDA-designated breakthrough device using targeted vibration therapy to prevent osteoporosis in postmenopausal women.

Pain News Network reports FDA grants Breakthrough Device status to Osteoboost, a wearable vibration belt aiding postmenopausal women with osteopenia.